Shuttle Pharmaceuticals ... (SHPH)
0.86
-0.02 (-1.85%)
At close: Jan 15, 2025, 1:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY18 | FY17 |
| Net Income | -6.59M | -3.03M | -1.15M | -805.73K | -626.14K | -213.59K |
| Depreciation & Amortization | 6.81K | 66.83K | 60.83K | 54.95K | 18.00K | 18.74K |
| Stock-Based Compensation | 181.96K | 403.96K | 910.07K | 459.59K | n/a | n/a |
| Other Working Capital | 66.57K | -172.32K | -3.65K | -106.02K | 19.64K | 10.83K |
| Other Non-Cash Items | 602.17K | 402.41K | 3.39K | 256.58K | 63.79K | 58.51K |
| Deferred Income Tax | n/a | n/a | -641.65K | n/a | n/a | n/a |
| Change in Working Capital | 220.63K | -555.21K | 519.15K | 7.78K | 16.65K | -9.03K |
| Operating Cash Flow | -5.58M | -2.71M | -300.34K | -26.83K | -566.69K | -202.71K |
| Capital Expenditures | -19.05K | n/a | n/a | -10.82K | n/a | n/a |
| Acquisitions | 3.02M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -3.00M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 187.90K | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -3.02M | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -2.83M | n/a | n/a | -10.82K | n/a | n/a |
| Debt Repayment | 2.92M | 600.72K | 687.93K | 70.07K | 205.87K | 160.52K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | -402.07K | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -345.00K | 428.75K | n/a | n/a | -250.00K | n/a |
| Financial Cash Flow | 2.57M | 10.62M | 687.93K | 70.07K | 868.37K | 160.62K |
| Net Cash Flow | -5.84M | 7.91M | 387.60K | 32.42K | 301.68K | -42.09K |
| Free Cash Flow | -5.60M | -2.71M | -300.34K | -37.65K | -566.69K | -202.71K |